CCB International believes that Corning Jerry Pharmaceutical...
CCB International believes that Corning Jerry Pharmaceuticals is becoming increasingly competitive in the field of NSCLC treatment, and that the reading of KN046-301 trial data that the company had previously postponed and the relevant data updates at ESMO 2023 did not increase the bank's confidence in its successful development of NSCLC treatment.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002292030a999424.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment